T. Schmitt

发表

The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin

A. Dimitrakopoulou-Strauss, A. Ho, B. Kasper, 2009, Marine drugs.

Intracellular vorinostat accumulation and its relationship to histone deacetylase activity in soft tissue sarcoma patients

W. Haefeli, G. Mikus, J. Burhenne, 2017, Cancer Chemotherapy and Pharmacology.

Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II study

A. Ho, S. Dietrich, B. Kasper, 2010, Bone Marrow Transplantation.

3431 Vorinostat in locally advanced and metastastic soft tissue sarcomas - results of a multi-center phase II trial (SAHA-1) of the German Sarcoma and GIST Working Group (AIO)

A. Ho, V. Grünwald, F. Mayer, 2015 .

Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphoma.

M. Ziepert, M. Pfreundschuh, S. Dietrich, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation.

H. Goldschmidt, A. Ho, T. Bruckner, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities

P. Schirmacher, R. Penzel, E. Wardelmann, 2014, Journal of Experimental & Clinical Cancer Research.

Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy

A. Ho, S. Dietrich, M. Witzens‐Harig, 2012, Leukemia & lymphoma.

Pentostatin for treatment of steroid-refractory acute GVHD: a retrospective single-center analysis

T. Luft, A. Ho, P. Dreger, 2011, Bone Marrow Transplantation.

[Fungal infections in hematology patients and after blood stem cell transplantation: prophylaxis and treatment].

G. Egerer, T. Schmitt, 2014, Medizinische Klinik, Intensivmedizin und Notfallmedizin.

Parenthood in long‐term survivors after CHOP with or without etoposide treatment for aggressive lymphoma

M. Ziepert, M. Pfreundschuh, A. Ho, 2014, British journal of haematology.

Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO).

A. Ho, V. Grünwald, F. Mayer, 2016, European journal of cancer.

New medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma

B. Kasper, T. Schmitt, 2009, Expert review of anticancer therapy.

TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities

P. Schirmacher, R. Penzel, E. Wardelmann, 2014, Journal of experimental & clinical cancer research : CR.

Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas

Roland Eils, Thomas Wolf, Volker Hovestadt, 2013, Genome Biology.

Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse

M. Görner, T. Luft, A. Ho, 2015, Bone Marrow Transplantation.

Trabectedin for Metastatic Soft Tissue Sarcoma: A Retrospective Single Center Analysis

A. Ho, S. Dietrich, G. Egerer, 2010, Marine drugs.

Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial.

H. Goldschmidt, A. Ho, G. Mikus, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial

J. Debus, M. Bischof, O. Sedlaczek, 2014, BMC Cancer.

Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity.

A. Krämer, A. Ho, U. Martens, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma

L. Strauss, A. Dimitrakopoulou-Strauss, A. Ho, 2011, BMC Cancer.

Submyeloablative total body irradiation‐based conditioning and allogeneic stem cell transplantation in high‐risk myeloma with early progression after up‐front autologous transplantation

H. Goldschmidt, T. Luft, A. Ho, 2021, British journal of haematology.

Gemcitabine and Docetaxel for Metastatic Soft Tissue Sarcoma - a Single Center Experience

A. Ho, G. Egerer, P. Wuchter, 2013, Oncology Research and Treatment.

Impact of Dynamic 18F-FDG PET on the Early Prediction of Therapy Outcome in Patients with High-Risk Soft-Tissue Sarcomas After Neoadjuvant Chemotherapy: A Feasibility Study

Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss, Ludwig G. Strauss, 2010, Journal of Nuclear Medicine.

Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis

Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss, Ludwig G. Strauss, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial

J. Debus, M. Bischof, O. Sedlaczek, 2013, BMC Cancer.